Piggybacking on nature: exploring the multifaceted world of porcine β-defensins

被引:1
作者
Finatto, Arthur Nery [1 ]
Meurens, Francois [2 ,3 ]
Costa, Matheus de Oliveira [1 ,4 ]
机构
[1] Univ Saskatchewan, Western Coll Vet Med, Large Anim Clin Sci, Saskatoon, SK S7N 5E2, Canada
[2] Univ Montreal, Fac Vet Med, Swine & Poultry Infect Dis Res Ctr, St Hyacinthe, PQ J2S 2M2, Canada
[3] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol & Immunol, Saskatoon, SK S7N 5E2, Canada
[4] Univ Utrecht, Fac Vet Med, Dept Populat Hlth, Utrecht, Netherlands
基金
加拿大自然科学与工程研究理事会;
关键词
Antimicrobial resistance; infection control; bactericidal activity; immunomodulatory features; swine; sustainability; PEPTIDOGLYCAN RECOGNITION PROTEINS; ANTIMICROBIAL PEPTIDES; IMMUNE-SYSTEM; NK-LYSIN; EXPRESSION; RESISTANCE; FAMILY; CATHELICIDINS; ANTIBIOTICS; INDUCTION;
D O I
10.1186/s13567-025-01465-4
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Porcine beta-defensins (pBDs) are cationic peptides that are classically associated with the innate immune system. These molecules yield both antimicrobial and immunomodulatory properties, as evidenced by various in vitro and animal trials. Researchers have revealed that enhancing pBD expression can be achieved through dietary components and gene editing techniques in pigs and porcine cell models. This state-of-the-art review aims to encapsulate the pivotal findings and progress made in the field of pBD over recent decades, with a specific emphasis on the biological role of pBD in infection control and its usage in clinical trials, thereby offering a new landscape of opportunities for research aimed at identifying prophylactic and therapeutic alternatives for both swine medicine and translational purposes.
引用
收藏
页数:13
相关论文
共 152 条
[1]  
Aarestrup Frank M., 2008, Animal Health Research Reviews, V9, P135, DOI 10.1017/S1466252308001503
[2]   Relative quantification of human β-defensins gene expression in pterygium and normal conjunctiva samples [J].
Abubakar, Sa'adatu Aliyu ;
Isa, Muhammad Mohd ;
Omar, Nazri ;
Tan, Sheau Wei .
MOLECULAR MEDICINE REPORTS, 2020, 22 (06) :4931-4937
[3]   Large-scale network analysis captures biological features of bacterial plasmids [J].
Acman, Mislav ;
van Dorp, Lucy ;
Santini, Joanne M. ;
Balloux, Francois .
NATURE COMMUNICATIONS, 2020, 11 (01)
[4]   Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: Linking systems biology with vaccine development [J].
Adams, L. Garry ;
Khare, Sangeeta ;
Lawhon, Sara D. ;
Rossetti, Carlos A. ;
Lewin, Harris A. ;
Lipton, Mary S. ;
Turse, Joshua E. ;
Wylie, Dennis C. ;
Bai, Yu ;
Drake, Kenneth L. .
VACCINE, 2011, 29 (41) :7197-7206
[5]   Molecular mechanisms related to colistin resistance in Enterobacteriaceae [J].
Aghapour, Zahra ;
Gholizadeh, Pourya ;
Ganbarov, Khudaverdi ;
Bialvaei, Abed Zahedi ;
Mahmood, Suhad Saad ;
Tanomand, Asghar ;
Yousefi, Mehdi ;
Asgharzadeh, Mohammad ;
Yousefi, Bahman ;
Kafil, Hossein Samadi .
INFECTION AND DRUG RESISTANCE, 2019, 12 :965-975
[6]   Linking Animal Welfare and Antibiotic Use in Pig Farming-A Review [J].
Albernaz-Goncalves, Rita ;
Olmos Antillon, Gabriela ;
Hotzel, Maria Jose .
ANIMALS, 2022, 12 (02)
[7]   A brief history of the antibiotic era: lessons learned and challenges for the future [J].
Aminov, Rustam I. .
FRONTIERS IN MICROBIOLOGY, 2010, 1
[8]   NK-LYSIN, A NOVEL EFFECTOR PEPTIDE OF CYTOTOXIC T-CELLS AND NK-CELLS - STRUCTURE AND CDNA CLONING OF THE PORCINE FORM, INDUCTION BY INTERLEUKIN-2, ANTIBACTERIAL AND ANTITUMOR-ACTIVITY [J].
ANDERSSON, M ;
GUNNE, H ;
AGERBERTH, B ;
BOMAN, A ;
BERGMAN, T ;
SILLARD, R ;
JORNVALL, H ;
MUTT, V ;
OLSSON, B ;
WIGZELL, H ;
DAGERLIND, A ;
BOMAN, HG ;
GUDMUNDSSON, GH .
EMBO JOURNAL, 1995, 14 (08) :1615-1625
[9]   NK-lysin, structure and function of a novel effector molecule of porcine T and NK cells [J].
Andersson, M ;
Gunne, H ;
Agerberth, B ;
Boman, A ;
Bergman, T ;
Olsson, B ;
Dagerlind, A ;
Wigzell, H ;
Boman, HG ;
Gudmundsson, GH .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 54 (1-4) :123-126
[10]   Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin [J].
Andrä, J ;
Koch, MHJ ;
Bartels, R ;
Brandenberg, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (05) :1593-1599